This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2011 Sep;147(9):1118-9.

doi: 10.1001/archdermatol.2011.241.

Interstitial granulomatous drug reaction to sorafenib

Cristina Martínez-Morán, Laura Nájera, Ana I Ruiz-Casado, Alberto Romero-Maté, Pablo Espinosa, Carmen Meseguer-Yebra, Susana Córdoba, Jesús M Borbujo

PMID: 21931061
DOI: 10.1001/archdermatol.2011.241

Case Reports

Interstitial granulomatous drug reaction to sorafenib

Cristina Martínez-Morán et al. Arch Dermatol. 2011 Sep.

. 2011 Sep;147(9):1118-9.

doi: 10.1001/archdermatol.2011.241.

Authors

Cristina Martínez-Morán, Laura Nájera, Ana I Ruiz-Casado, Alberto Romero-Maté, Pablo Espinosa, Carmen Meseguer-Yebra, Susana Córdoba, Jesús M Borbujo

PMID: 21931061
DOI: 10.1001/archdermatol.2011.241

No abstract available

PubMed Disclaimer

Similar articles

[Palmoplantar cutaneous reaction to sorafenib].
Echeverría B, Llombart B, Botella-Estrada R, Guillén C. Echeverría B, et al. Actas Dermosifiliogr. 2009 Oct;100(8):736-7. Actas Dermosifiliogr. 2009. PMID: 19775561 Spanish. No abstract available.
Severe sorafenib-induced hand-foot skin reaction.
Cuesta L, Betlloch I, Toledo F, Latorre N, Monteagudo A. Cuesta L, et al. Dermatol Online J. 2011 May 15;17(5):14. Dermatol Online J. 2011. PMID: 21635836
Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.
Yang CH, Lin WC, Chuang CK, Chang YC, Pang ST, Lin YC, Kuo TT, Hsieh JJ, Chang JW. Yang CH, et al. Br J Dermatol. 2008 Mar;158(3):592-6. doi: 10.1111/j.1365-2133.2007.08357.x. Epub 2007 Dec 6. Br J Dermatol. 2008. PMID: 18070211
Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.
McLellan B, Kerr H. McLellan B, et al. Dermatol Ther. 2011 Jul-Aug;24(4):396-400. doi: 10.1111/j.1529-8019.2011.01435.x. Dermatol Ther. 2011. PMID: 21910797 Review.
Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
Lipworth AD, Robert C, Zhu AX. Lipworth AD, et al. Oncology. 2009;77(5):257-71. doi: 10.1159/000258880. Epub 2009 Nov 16. Oncology. 2009. PMID: 19923864 Review.

See all similar articles

Cited by

A case report of bosutinib-induced interstitial granulomatous drug reaction in a patient with chronic myelogenous leukemia: a case report.
Aria AB, Chen L, Huen AO. Aria AB, et al. SAGE Open Med Case Rep. 2018 Sep 10;6:2050313X18795075. doi: 10.1177/2050313X18795075. eCollection 2018. SAGE Open Med Case Rep. 2018. PMID: 30214807 Free PMC article.
Interstitial granulomatous dermatitis successfully treated with etanercept.
Ahmed ZS, Joad S, Singh M, Bandagi SS. Ahmed ZS, et al. Am J Case Rep. 2014 Mar 1;15:94-6. doi: 10.12659/AJCR.890074. eCollection 2014. Am J Case Rep. 2014. PMID: 24624249 Free PMC article.
Granulomatous Cutaneous Drug Eruptions: A Systematic Review.
Shah N, Shah M, Drucker AM, Shear NH, Ziv M, Dodiuk-Gad RP. Shah N, et al. Am J Clin Dermatol. 2021 Jan;22(1):39-53. doi: 10.1007/s40257-020-00566-4. Am J Clin Dermatol. 2021. PMID: 33108647

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems